Sunicine 50mg Capsule
By Sunicine
Rx
28 Capsule in a Bottle

Composition
Sunitinib(50mg)

Manufacturer - Arechar Healthcare
Office No 08, Ground Floor Gagandeep Building, Rajindera Place, New Delhi -110008

Expires on or after
September, 2025

liver
Sunicine 50mg Capsule is considered safe for use in patients with liver disease, and it does not require any dose adjustment. This means that individuals with liver issues can generally take Sunicine 50mg Capsule without specific concerns about their liver condition impacting the dosage.

kidney
Sunicine 50mg Capsule is safe for patients with kidney disease. No dose adjustment is needed for this medication.

alcohol
Consult your doctor when consuming alcohol with Sunicine 50mg Capsule.

driving
During Sunicine 50mg Capsule treatment, be cautious as it may cause dizziness, affecting your ability to drive or operate machinery. If you experience dizziness, avoid driving.

pregnancy
Sunicine 50mg Capsule may not be safe during pregnancy as animal studies suggest potential harm to the developing baby. Your doctor will evaluate the benefits and risks before prescribing it. Please consult your doctor before using this medication during pregnancy.

breastfeeding
Sunicine 50mg Capsule is likely unsafe for breastfeeding mothers. Limited data indicates the drug might transfer to breastmilk and cause harm to the baby.
Habit Forming | No |
Chemical Class | Indole and Pyrrole Derivative |
Therapeutic Class | - |
Action Class | - |
₹7150
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024